Dengue virus infection: a tale of viral exploitations and host responses

N Nanaware, A Banerjee, S Mullick Bagchi, P Bagchi… - Viruses, 2021 - mdpi.com
Dengue is a mosquito-borne viral disease (arboviral) caused by the Dengue virus. It is one
of the prominent public health problems in tropical and subtropical regions with no effective …

Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: An update

A Higuera, JD Ramírez - Acta tropica, 2019 - Elsevier
Arboviruses are a group of viruses transmitted by arthropods. They are characterized by a
wide geographic distribution, which is associated with the presence of the vector, and cause …

MPD3: a useful medicinal plants database for drug designing

A Mumtaz, UA Ashfaq, MT ul Qamar… - Natural product …, 2017 - Taylor & Francis
Medicinal plants are the main natural pools for the discovery and development of new drugs.
In the modern era of computer-aided drug designing (CADD), there is need of prompt efforts …

Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro

AM Paul, Y Shi, D Acharya… - Journal of general …, 2014 - microbiologyresearch.org
Dengue virus (DENV) infection in humans can cause flu-like illness, life-threatening
haemorrhagic fever or even death. There is no specific anti-DENV therapeutic or approved …

[HTML][HTML] Zika virus infection—the next wave after dengue?

SSY Wong, RWS Poon, SCY Wong - Journal of the Formosan Medical …, 2016 - Elsevier
Zika virus was initially discovered in east Africa about 70 years ago and remained a
neglected arboviral disease in Africa and Southeast Asia. The virus first came into the …

Nanopharmaceuticals as a solution to neglected diseases: Is it possible?

GA Islan, M Durán, ML Cacicedo, G Nakazato… - Acta tropica, 2017 - Elsevier
The study of neglected diseases has not received much attention, especially from public and
private institutions over the last years, in terms of strong support for developing treatment for …

Antiviral effects of Curcuma longa L. against dengue virus in vitro and in vivo

M Ichsyani, A Ridhanya, M Risanti… - … Series: Earth and …, 2017 - iopscience.iop.org
Dengue is the most common infective disease caused by dengue virus (DENV) and
endemic diseases in tropical and subtropical areas. Until now, there is no specific antiviral …

Trends of dengue infections in Malaysia, 2000-2010

MS Mia, RA Begum, AC Er, RDZRZ Abidin… - Asian Pacific journal of …, 2013 - Elsevier
OBJECTIVE: To analyze trends of dengue incidences and deaths in Malaysia from 2000 to
2010 as well as the predominant dengue virus serotypes during the last decade. METHODS …

Viral vectors applied for RNAi-based antiviral therapy

K Lundstrom - Viruses, 2020 - mdpi.com
RNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of
RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro …

Genetically Modified Aedes aegypti to Control Dengue: A Review

M Qsim, UA Ashfaq, MZ Yousaf… - Critical Reviews™ in …, 2017 - dl.begellhouse.com
Dengue is an acute infectious disease of viral etiology characterized by lymphadenopathy,
leucopenia, headache, biphasic fever, pain in various parts of the body, rashes, and extreme …